Zymeworks (ZYME) is expected to be added to the Nasdaq Biotechnology Index (NBI). Zymeworks’ addition to the NBI will become effective prior to the market open on Monday, December 18, 2023.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ZYME:
- Zymeworks Announces Participation in Upcoming Investor Conference
- Cantor biotech/biopharma analysts hold analyst/industry conference call
- Zymeworks reports Q3 EPS (41c), consensus (47c)
- Zymeworks Provides Corporate Update and Reports Third Quarter 2023 Financial Results
- Zymeworks Announces Participation in Upcoming Investor Conferences
